Food and Drug Administration--Press Releases

Press releases from FDA

FDA warns consumers not to use Vigor-25

11/19/2010 01:15 PM

Marketed as a ’male sexual stimulant,’ product contains hidden drug ingredient The U.S. Food and Drug Administration says Vigor-25, a product marketed as a natural dietary supplement to enhance male sexual performance, should not be purchased or used because it contains sildenafil, the active ingredient in the prescription drug Viagra.

Xanodyne agrees to withdraw propoxyphene from the U.S. market

11/19/2010 10:32 AM

Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the painkiller propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food Administration. The FDA has also informed generic manufacturers of Xanodyne’s decision and they will be removing their propoxyphene-containing products from the market as well.

FDA approves Xgeva to help prevent cancer-related bone injury

11/19/2010 08:52 AM

Xgeva, cancer

FDA Warning Letters issued to four makers of caffeinated alcoholic beverages

11/17/2010 12:31 PM

The U.S. Food and Drug Administration today warned four companies that the caffeine added to their malt alcoholic beverages is an “unsafe food additive” and said that further action, including seizure of their products, is possible under federal law. (DSK)

FDA approves new treatment option for late-stage breast cancer

11/15/2010 01:06 PM

Halaven, metastatic breast cancer

FDA launches initiative to develop innovative external defibrillators

11/15/2010 01:18 PM

Safety concerns on the devices that treat abnormal heart rhythms also to be addressed. The U.S. Food and Drug Administration today announced a program aimed at facilitating the development of safer, more effective external defibrillators used to treat abnormal heart rhythms through improved design and manufacturing practices.

FDA Urges Consumers to be ‘Smart’ about Antibiotic Use

11/15/2010 10:58 AM

This year, millions of antibiotics will be prescribed. Antibiotics can be used to treat bacterial infections; however, they are commonly over-prescribed. Patients sometimes ask their health care professional to prescribe antibiotic drugs for viral infections, like the common cold, despite the fact that they will not work and may lead to potentially harmful side effects. The misuse of antibiotics has contributed to one of the world’s most pressing public health problems today, antibiotic resistance.

FDA: Lot of Mauri Gorgonzola cheese positive for E. coli 0157:H7

11/10/2010 10:46 PM

Mauri Gorgonzola cheese with sell-by dates of 01/31/11 and 01/14/11 is being recalled because of a positive test for E. coli 0157:H7. DPI Specialty Foods of Tualatin, Ore., cut, packaged and distributed the cheese to Costco Wholesale Corporation (Costco) stores in Colorado.

FDA Approves Egrifta to Treat Lipodystrophy in HIV Patients

11/10/2010 06:29 PM

lipodystrophy

Pharmaceutical Company Lawyer Charged with Obstruction and Making False Statements

11/10/2010 11:41 AM

Pharmaceutical Company Lawyer Charged with Obstruction and Making False Statements

FDA: Majority of drug and biological product makers meeting postmarketing requirements and commitments

11/09/2010 06:19 PM

Most makers of approved drug and biological products are meeting their regulatory obligations and meeting targets for postmarketing studies/clinical trials in a timely manner, according to a study released today by the U.S. Food and Drug Administration (FDA).

FDA working to prevent radiation overdoses during CT scans

11/09/2010 09:01 AM

The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.

FDA, State of Maryland, and Baugher Enterprise warn consumers to avoid Baugher’s Apple Cider

11/05/2010 10:18 PM

The U.S. Food and Drug Administration and the Maryland Department of Health and Mental Hygiene (DHMH) join Baugher Enterprise in warning consumers to not consume Baugher’s Apple Cider, as this cider may be associated with an outbreak of E. coli O157:H7 infections. The cider was available for sale in Maryland and Pennsylvania. (DSK)

FDA, CDC, and Costco warn consumers to avoid Bravo Farms Dutch Style Gouda cheese

11/04/2010 10:15 PM

• Bravo Farms Dutch Style Gouda cheese, (Costco item 40654) offered for sale and in cheese sampling events at Costco Wholesale Corporation (Costco) locations is preliminarily linked with an outbreak of E.coli O157:H7 infections.

FDA clears Cymbalta to treat chronic musculoskeletal pain

11/04/2010 06:15 PM

The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. Cymbalta was first used to treat major depressive disorder in 2004.

FDA reclassifies certain digital mammography devices today

11/04/2010 09:23 AM

Devices capturing digital image of breasts to be Class II. The U.S. Food and Drug Administration today announced that it is easing the pathway to market for mammography systems that produce computerized X-ray images of the entire breast.

FDA, USDA, Cornell University announce alliance for produce safety

11/04/2010 09:55 AM

A public-private organization will provide produce growers and packagers with fundamental, on-farm food safety knowledge, in advance of a proposed produce safety regulation, the U.S. Food and Drug Administration, the U.S. Department of Agriculture’s Agricultural Marketing Service (USDA/AMS), and Cornell University announced today. (DSK)

FDA, University of Rochester announce partnership for new drug products

11/01/2010 01:14 PM

The U.S. Food and Drug Administration today announced a partnership agreement with the University of Rochester to form the Analgesic Clinical Trial Innovations, Opportunities, and Networks (ACTION) Initiative.

FDA approves new indication for Afinitor

11/01/2010 09:56 AM

SEGA, Afinitor, tumors

NOAA and FDA Announce Chemical Test for Dispersant in Gulf Seafood

10/29/2010 02:40 PM

Building upon the extensive testing and protocols already in use by federal, state and local officials for the fishing waters of the Gulf, NOAA and FDA have developed and are using a chemical test to detect dispersants used in the Deepwater Horizon-BP oil spill in fish, oysters, crab and shrimp. Trace amounts of the chemicals used in dispersants are common, and levels for safety have been previously set.



Political Feeds ~  RSS Editor ~ Financial Feeds ~ Police Supplies 


Copyright 2006 All Rights Reserved